The concept of essential medicines: lessons for rich countries

被引：85

作者：

Hogerzeil, HV ^{[1
]}

机构：

[1] WHO, Drugs & Med Policy, CH-1211 Geneva, Switzerland

来源：

BRITISH MEDICAL JOURNAL | 2004年 / 329卷 / 7475期

关键词：

D O I：

10.1136/bmj.329.7475.1169

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1169 / 1172

页数：8

共 25 条

[1]

[Anonymous], VAD OFF MED BAS SECT

[2]

[Anonymous], STANDARD NOTES TANZA

[3]

*COMM DEP HLTH AG, 2000, NAT MED POL

[4]

*DEP HLTH, 1999, PHIL NAT DRUG POL

[5]

*DEP HLTH, 2003, STAND TREATM GUID ES

[6] BASING PRESCRIPTION DRUG PAYMENT ON ECONOMIC-ANALYSIS - THE CASE OF AUSTRALIA [J].

DRUMMOND, MF .

HEALTH AFFAIRS, 1992, 11 (04) :191-196

[7] A NATIONAL SURVEY OF THE ARRANGEMENTS MANAGED-CARE PLANS MAKE WITH PHYSICIANS [J].

GOLD, MR ;

HURLEY, R ;

LAKE, T ;

ENSOR, T ;

BERENSON, R .

NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (25) :1678-1683

[8] EFFECT OF CLINICAL GUIDELINES ON MEDICAL-PRACTICE - A SYSTEMATIC REVIEW OF RIGOROUS EVALUATIONS [J].

GRIMSHAW, JM ;

RUSSELL, IT .

LANCET, 1993, 342 (8883) :1317-1322

[9]

Kafuko J, 1994, IMPACT NATL STANDARD

[10] Ten recommendations to improve use of medicines in developing countries [J].

Laing, RO ;

Hogerzeil, HV ;

Ross-Degnan, D .

HEALTH POLICY AND PLANNING, 2001, 16 (01) :13-20

← 1 2 3 →